In colon cancer cells, they suppress the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) genes and inhibit mitogen induced metabolic pathways (Serra et al., 2013). The gene discussed is NOS2; the disease is malignant colon neoplasm.